Stay updated on Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedFooter revision updated from v3.6.3 to v3.6.4, indicating a newer build of the page.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2, signaling a new page revision was published. This appears to be a minor maintenance update and does not change the study details.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 on the page, indicating a minor update to the page. It does not affect the study details or data shown.SummaryDifference0.0%

- Check53 days agoChange DetectedUpdated the page to reflect revision v3.6.0 (2026-06-12) by adding new study contact details for Veronika Bachanova (MD) with phone and email, removing older contacts such as Erin Zielinski, and introducing new help/navigation sections (Check who can join, How to Read a Study Record, Common Questions, How to Join a Study).SummaryDifference0.9%

- Check60 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the page was published. This typically accompanies small fixes or clarifications and does not alter the study details.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new deployment of the page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial page.